Cargando…
Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis
Fibrosis, characterized by increased extracellular matrix (ECM) deposition, and widespread vasculopathy, has the prominent trait of chronic hypoxia. Hypoxia inducible factors-1α (HIF-1α), a key transcriptional factor in response to this chronic hypoxia, is involved in fibrotic disease, such as Syste...
Autores principales: | Xiong, Anji, Liu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447768/ https://www.ncbi.nlm.nih.gov/pubmed/28611671 http://dx.doi.org/10.3389/fphar.2017.00326 |
Ejemplares similares
-
Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis
por: Hua, Susan, et al.
Publicado: (2016) -
Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review
por: Luo, Shuang, et al.
Publicado: (2022) -
T-Cell Exhaustion Status Under High and Low Levels of Hypoxia-Inducible Factor 1α Expression in Glioma
por: Liu, Shuai, et al.
Publicado: (2021) -
Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis
por: Zhu, Shuyan, et al.
Publicado: (2022) -
Hypoxia and Hypoxia-Inducible Factors in Lymphedema
por: Jiang, Xinguo, et al.
Publicado: (2022)